Northern Trust’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
VCM
NCNMGF
SAM
KCM
FCM
RI
MBAM
Northern Trust's XGN Position: Q1 2026 in Review
Northern Trust held its Exagen (XGN) position steady in Q1 2026 at 37,549 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #4072.
Northern Trust first reported a position in XGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.46M in Q2 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- Northern Trust held 37,549 shares of Exagen worth $113K as of Q1 2026.
- Northern Trust left its Exagen share count unchanged in Q1 2026.
- Exagen made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4072 holding.
- Northern Trust first reported a position in Exagen in Q4 2019 and has held it in 26 quarters since.
- Northern Trust's Exagen position peaked at $1.46M in Q2 2021.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.